Menu
Microsoft strongly encourages users to switch to a different browser than Internet Explorer as it no longer meets modern web and security standards. Therefore we cannot guarantee that our site fully works in Internet Explorer. You can use Chrome or Firefox instead.

Number of shares and voting rights as at 30 September 2014



Article L.233-8-II of Commercial Law (Code de commerce) and


Article 223-16 of the General Regulation of the French Financial Markets Authority

(AMF – Autorité des Marchés Financiers)






30.09.2014






























Total number of outstanding shares forming the capital


  • 9,194,111 ordinary shares under ISIN FR0000054694

  • 822 shares issued from stock-options under ISIN FR0000054694
 

9,194,933
Number of shares with double voting rights 870,986
Total number of gross voting rights 10,065,919
 

Number of shares without voting rights


  • 11,433 bearer shares in the frame of the liquidity contract
 

11,433
Total number of exercisable voting rights*  

10,054,486

 

*Real number of voting rights = total number of voting rights – number of shares without voting rights




If you would like to receive financial information about Naturex by e-mail, go to: www.naturex.com






Financial schedule








- 2014 third-quarter sales

- 2014 third-quarter results

- Annual revenue

- Annual results
4 November 2014

28 November 2014

3 February 2015

31 March 2015

Upcoming events








- ACTIONARIA Show (Paris) 21-22 November 2014



Naturex has been listed since October 1996 on Euronext in Paris, Segment B








NATUREX Total number of shares comprising the share capital: 9,194,933 (September 2014)

ISIN FR0000054694



NATUREX is a component of the CAC®PME, CAC Small and Gaïa indexes.

Naturex is eligible for the "long only" Deferred Settlement Service (SRD) and French equity plans (PEA and PEA-PME).

Naturex established a Sponsored Level 1 American Depositary Receipt (ADR) program in the United States. Under this facility, Naturex's ADRs are traded over-the-counter in the United States under the symbol NTUXY.



TICKER: NRX - Reuters: NATU.PA - Bloomberg: NRX:FP - DR Symbol: NTUXY



About Naturex


Naturex is the global leader in speciality plant-based natural ingredients. The Group is organised around three strategic markets (food & beverage, nutrition & health and personal care) and produces and markets speciality plant-based ingredients for the food, nutraceutical, pharmaceutical and cosmetic industries.


Naturex's head office is based in Avignon. The company employs 1,600 people with 8 sourcing offices located throughout the world and high-performance manufacturing operations across 16 sites in Europe, Morocco, the United States, Brazil, Australia and India. It also has a global commercial presence through a dedicated network of sales offices in more than 20 countries.

 
















Contacts  
 

Carole Alexandre

Investor Relations

Tel.: +33 (0)4 90 23 78 28

[email protected]

 

 

Thierry-Bertrand Lambert

Chief Financial Officer

Tel.: +33 (0)4 90 23 96 89

[email protected]

 
Anne Catherine Bonjour

Actus Finance Press Relations

Tel.: +33 (0)1 53 67 36 93

[email protected]

 
 

Information réglementée
Information relative au nombre total de droits de vote et d'actions composant le capital :

-

Communiqué intégral et original au format PDF :


http://www.actusnews.com/documents_communiques/ACTUS-0-37448-2014.10.06-Nb-of-shares-and-voting-rights_September-2014.pdf

© Copyright Actusnews Wire

Recevez gratuitement par email les prochains communiqués de la société en vous inscrivant sur www.actusnews.com

Receive by email the next press releases of the company by registering on www.actusnews.com, it's free



Quelle: Actusnews

Like: 0
Share

Comments